Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weon Kim

Showing results (681-690 of 710) with videos related to

Pageof 71
Sort By:
American Heart Journal|April 19, 2024
Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trialMin Chul Kim, Joon Ho Ahn, Dae Young Hyun, et al.
Lancet (London, England)|April 13, 2026
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 studyNicoletta Colombo, Emese Zsiros, Gabriella Parma, et al.
Korean Circulation Journal|November 27, 2024
Cost-effectiveness of Fractional Flow Reserve Versus Intravascular Ultrasound to Guide Percutaneous Coronary Intervention: Results From the FLAVOUR StudyDoyeon Hwang, Hea-Lim Kim, Jane Ko, et al.
Yonsei Medical Journal|December 8, 2017
Effectiveness and Safety of Biolimus A9™-Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study)Keun Ho Park, Myung Ho Jeong, Young Joon Hong, et al.
Lancet (London, England)|September 3, 2025
Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trialMin Chul Kim, Joon Ho Ahn, Dae Young Hyun, et al.
European Heart Journal|January 6, 2026
Complete revascularization timing in ST-segment elevation myocardial infarction and multivessel disease with heart failure: the OPTION-STEMI trialMin Chul Kim, Joon Ho Ahn, Dae Young Hyun, et al.
Korean Circulation Journal|July 3, 2024
Discordance Between Angiographic Assessment and Fractional Flow Reserve or Intravascular Ultrasound in Intermediate Coronary Lesions: A Post-hoc Analysis of the FLAVOUR TrialJung-Hee Lee, Sung Gyun Ahn, Ho Sung Jeon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 27, 2023
Gestational choriocarcinomaGiorgio Bogani, Isabelle Ray-Coquard, David Mutch, et al.
Cancers|October 16, 2024
From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next StepsKyung-Jin Min, Nam Kyeong Kim, Jae-Yun Song, et al.
JACC. Cardiovascular Interventions|January 10, 2026
Long-Term Prognostic Impact of Changes in Coronary Angiography-Derived Index of Microcirculatory Resistance Following PCIYuxuan Zhang, Jiacheng Fang, Zining Chen, et al.
Pageof 71

Showing results (681-690 of 710) with videos related to

Sort By:
Pageof 71
American Heart Journal|April 19, 2024
Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trialMin Chul Kim, Joon Ho Ahn, Dae Young Hyun, et al.
Lancet (London, England)|April 13, 2026
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 studyNicoletta Colombo, Emese Zsiros, Gabriella Parma, et al.
Korean Circulation Journal|November 27, 2024
Cost-effectiveness of Fractional Flow Reserve Versus Intravascular Ultrasound to Guide Percutaneous Coronary Intervention: Results From the FLAVOUR StudyDoyeon Hwang, Hea-Lim Kim, Jane Ko, et al.
Yonsei Medical Journal|December 8, 2017
Effectiveness and Safety of Biolimus A9™-Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study)Keun Ho Park, Myung Ho Jeong, Young Joon Hong, et al.
Lancet (London, England)|September 3, 2025
Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trialMin Chul Kim, Joon Ho Ahn, Dae Young Hyun, et al.
European Heart Journal|January 6, 2026
Complete revascularization timing in ST-segment elevation myocardial infarction and multivessel disease with heart failure: the OPTION-STEMI trialMin Chul Kim, Joon Ho Ahn, Dae Young Hyun, et al.
Korean Circulation Journal|July 3, 2024
Discordance Between Angiographic Assessment and Fractional Flow Reserve or Intravascular Ultrasound in Intermediate Coronary Lesions: A Post-hoc Analysis of the FLAVOUR TrialJung-Hee Lee, Sung Gyun Ahn, Ho Sung Jeon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 27, 2023
Gestational choriocarcinomaGiorgio Bogani, Isabelle Ray-Coquard, David Mutch, et al.
Cancers|October 16, 2024
From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next StepsKyung-Jin Min, Nam Kyeong Kim, Jae-Yun Song, et al.
JACC. Cardiovascular Interventions|January 10, 2026
Long-Term Prognostic Impact of Changes in Coronary Angiography-Derived Index of Microcirculatory Resistance Following PCIYuxuan Zhang, Jiacheng Fang, Zining Chen, et al.
Pageof 71